EQS-News: aap Implantate AG / Key word(s): Regulatory Approval
aap Implantate AG: Full admission of all previously unadmitted shares, introduction to stock exchange trading and termination of lock-up agreements
01.08.2025 / 12:15 CET/CEST
The issuer is solely responsible for the content of this announcement.
aap Implantate AG (the “Company“) announces that all previously unadmitted shares of the Company (previously ISIN DE000A32VP65 and DE000A4096G8) are now fully admitted to trading on the regulated market of the Frankfurt Stock Exchange (General Standard). The admission decision of the Frankfurt Stock Exchange is available at: https://www.aap.de/investoren/aktienzulassung-2025. The introduction of the shares to the regulated market is planned for August 4, 2025.
As a result, from August 5, 2025, all shares of the Company will be tradable exclusively under the existing ordinary ISIN without restrictions. This also includes those…
